Movie Industry

'Spider-Man 4' Tops Box Office for 7 Consecutive Days… Cumulative Attendance Reaches 4.13 Million

No. 2: 'Hope' · No. 3: 'Minions & Monsters'

Choi Hee-jae
2026-08-05 09:02:06
[Edaily Starin Choi Hee-jae Reporter] The movie "Spider-Man: Brand New Day" (Spider-Man 4) continues its box office run in its second week of release.
Still from the movie “Spider-Man: A Brand New Day” (Photo courtesy of Sony Pictures)

According to the Korean Film Council’s integrated computer network on the 5th, “Spider-Man 4” took the top spot at the box office on the 4th, drawing 348,262 viewers. Its cumulative audience stands at 4,134,163.
In second place was Director Na Hong-jin’s “Hope,” which drew 61,228 viewers on the day, bringing its cumulative total to 4,235,700.
“Minions & Monsters” took third place and “Toy Story 5” fourth, as animated films continue their long-running success. “Minions & Monsters” drew 12,339 viewers that day, while “Toy Story 5” drew 7,890. Fifth place went to Disney’s “Moana,” a live-action adaptation of the animated film.
Today (the 5th) marks the release of director Christopher Nolan’s new film *The Odyssey* and the Korean animated film *Love’s Hachuping: The Legend of the Whale Jewel*. With highly anticipated films opening one after another, competition in the summer box office is expected to become even more intense.
“Spider-Man 4” is an action blockbuster in which Peter Parker—forgotten by everyone following the events of “Spider-Man: No Way Home”—is plunged into even deeper turmoil by the appearance of a mysterious enemy who remembers his true identity and by DNA mutations that grant him uncontrollable powers. He must face a new threat to protect those he loves. The film is currently playing in theaters nationwide.

Economy

Corporation

IT·Science

Economy

[Market In] E-Land World Moves to Issue 40 Billion Won in Corporate Bonds, Defying the BBB-Rating Downturn

E-Land World (BBB0) is set to issue up to 40 billion won in public corporate bonds. With investor sentiment toward BBB-rated corporate bonds currently subdued, all eyes are on whether the company can …
2026-08-07 18:54:04

Corporation

MedPacto, Inc. Adds Medium-Dose Group to Phase 2 Trial of Baekto-Seetip for Osteosarcoma… Files Application to Amend IND

(Photo courtesy of MedPacto, Inc.) MedPacto, Inc.(235980)is adding a medium-dose patient group to the Phase 2 clinical trial of “Vactosertib,” which it is developing as a treatment for osteosarcom…
2026-08-07 18:21:02

IT·Science

Coreline Soft Co., Ltd. Signs Contract for Lung Cancer Screening Project in Germany… A 10-Year “Jackpot”

Medical artificial intelligence (AI) company Coreline Soft Co., Ltd.(384470)announced on the 7th that it has secured a contract for a lung cancer screening project in Lostau, Germany, through Canon Me…
2026-08-07 18:44:02